Cellular senescence itself is a complex cell state, and expert consensus literature emphasizes that senescence requires careful marker selection and model-specific interpretation [6]
Reid M, Maras JE, Shea S, et al
This is meaningful news for many of our patients, particularly those who have been unable to access medications like Wegovy or Zepbound through Medicare
Consider fibre supplements if you cant meet needs through diet
study documented significantly accelerated tendon-to-bone healing in rat rotator cuff models compared to untreated controls, with VEGF pathway upregulation as a proposed mechanism [1]
Here are some potential benefits of switching: More and faster weight loss Better blood glucose control, especially when weight loss has plateaued Drug availability, as tirzepatide may be easier to find right now Lower cost, with tirzepatide being about $300 less per month without insurance Risks and Potential Drawbacks of Switching Switching from semaglutide to tirzepatide can come with potential risks and drawbacks beyond just the common side effects